Examining non-invasive ventilation for bronchial dilatation disease
Official title: Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease (BRONCHINIV)
Run by Centre Hospitalier Intercommunal Creteil · NCT06987461 · Data updated 2026-11-12
This study looks at how well long-term non-invasive ventilation helps people with bronchial dilatation disease manage their symptoms and stay out of the hospital.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Locations | 5 sites (Créteil and 4 other locations) |
| Status | Recruiting |
| Started | January 6, 2025 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | May 23, 2025 |
| Trial ID | NCT06987461 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years with a predominant diagnosis of bronchiectatic disease confirmed by CT scans, who have been treated with long-term NIV.
✕Probably not a fit
Patients with cystic fibrosis, predominant diagnoses of COPD or asthma, or other specified conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects medical record data to analyze the characteristics of patients with bronchial dilatation disease who are treated with long-term non-invasive ventilation (NIV). It aims to assess epidemiological factors, reasons for initiating NIV, and methods of NIV adjustment. The study is retrospective and focuses on understanding the effectiveness of NIV in managing exacerbations, hospital admissions, and mortality rates among these patients. By analyzing existing medical records, the study seeks to improve patient management strategies.
Why it matters
Potential benefit: If successful, this study could enhance the management and treatment outcomes for patients with bronchial dilatation disease using non-invasive ventilation.
How similar studies have gone: While this study explores a relatively untested area regarding the efficacy of NIV in bronchial dilatation disease, similar observational studies have shown promise in understanding treatment outcomes in other respiratory conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years * Predominant diagnosis of bronchiectatic disease, excluding cystic fibrosis, confirmed by computed tomography * Introduction of long-term NIV at a given point in the patient's care Exclusion Criteria: * Patient's opposition to participating in this study * Cystic fibrosis * Predominant diagnosis of COPD or asthma, traction bronchiectasis, bronchiectasis resulting from focal endobronchial lesion, sarcoidosis or active allergic bronchopulmonary aspergillosis.
Where it's running
-
Centre Hospitalier Intercommunal de Créteil
Créteil, France Recruiting -
Centre Hospitalier Universitaire Henri Mondor
Créteil, France Recruiting -
Centre Hospitalier Universitaire de Dijon
Dijon, France Not yet recruiting -
Centre Hospitalier Universitaire de Rennes
Rennes, France Not yet recruiting -
Centre Hospitalier Universitaire Toulouse
Toulouse, France Not yet recruiting
Study contacts
- Study coordinator: Suela DEMIRI, Doctor, Hospital Practitioner
- Email: suela.demiri@chicreteil.fr
- Phone: 01 57 02 29 63
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Immune and microbial environment profile in young infants with RSV bronchiolitis
The study tests the immune and microbiome signatures in infants ≤6 months with RSV-related bronchiolitis, using nasal swabs and blood samples when possible.
-
Post-Emergency Antibiotic Optimization for UTI
In people who come to the emergency department with a suspected urinary tract infection, this study looks at how doctors can adjust antibiotic therapy after urine culture results to use the right antibiotic and reduce overuse.
-
Diaphragmatic swing by CPAP flow in very preterm babies
This study tests whether constant-flow CPAP with a nasal mask works as well as variable-flow CPAP with a nasal mask for supporting breathing in preterm babies 32 weeks or earlier gestational age.
-
Outcomes after emergency gynecology care for pelvic endometriosis or suspected endometriosis
This project will follow adults who come to a gynecological emergency department with known or suspected endometriosis to see what their outcomes are after emergency care.
-
Understanding barriers and delays in diagnosing anal cancer
This study looks at how people with anal cancer experience delays in diagnosis to see what helps or hinders earlier detection.
-
Fixed 3.66 mcg Rekovelle (follitropin delta) for ovarian stimulation before intrauterine insemination
This test tries a fixed 3.66 mcg dose of Rekovelle (follitropin delta) to stimulate the ovaries of women 18–38 with regular cycles undergoing their first IUI to encourage two follicles and reduce the chance of multiple pregnancy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.